In Silico Molecular Docking Analysis of Natural Pyridoacridines as Anticancer Agents

Figure 5

Ligand-interaction diagrams of KIs, that is, Palbociclib and SU9516, against CDK-6 and CDK-2 macromolecules, respectively.